Accordingly, we propose that specific antagonists of the pathological actions of F11R represent a new target for the development of novel drugs for the prevention and treatment of atherosclerosis, heart attacks, stroke, and other cardiovascular disorders triggered by inflammatory processes. Here, F11R is linked to Stroke.